RITHOLTZ WEALTH MANAGEMENT
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1698218
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,103,665
+$15,788 QoQ
Shares Held
1,770
+25.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#625
of 1,322 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RITHOLTZ WEALTH MANAGEMENT holds $36,393,027 across 25 Biotechnology names. REGN ranks #10 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AUPH |
Aurinia Pharmaceuticals Inc.
|
363,056 | $6,161,060 | |
| 2 | PBYI |
Puma Biotechnology, Inc.
|
749,798 | $6,080,861 | |
| 3 | EXEL |
Exelixis, Inc.
|
68,589 | $3,731,927 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
|
94,450 | $3,694,884 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
13,306 | $3,206,346 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,709 | $2,339,101 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
25,095 | $2,046,999 | |
| 8 | INVA |
Innoviva, Inc.
|
52,793 | $1,198,929 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,103,665 | 1,770 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,087,877 | 1,408 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $954,031 | 1,236 | Shares | Sole | 2026-01-23 | |
| 2025-06-30 | $202,650 | 386 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $308,235 | 486 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $321,260 | 451 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $766,353 | 729 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $651,638 | 620 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $544,769 | 566 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $436,510 | 497 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $419,709 | 510 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $309,690 | 431 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $406,726 | 495 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $368,681 | 511 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,079,459 | 1,567 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $419,111 | 709 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $466,544 | 668 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $382,069 | 605 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $364,318 | 602 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $359,141 | 643 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $299,497 | 633 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $294,697 | 610 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $332,509 | 594 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $558,790 | 896 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $390,632 | 800 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||